Loading…
← CockpitCompetitor Analysis › 600866.SS Star Lake Bioscience Co., Inc. Class AOpen in the cockpit ↗

Star Lake Bioscience Co., Inc. Class A600866.SSCompetitor analysis, valuation and peers

China · CNY·Consumer Staples›Food: Specialty/Candy

Guangdong biochemical company producing MSG, nucleotides and other fermentation-based food additives and fine chemicals.

≈ A smaller Chinese fermentation/food-additive producerMomentum neutral 54
Mkt cap
$1.07B
US dollars, full cap
Free float
55%
of shares outstanding
$/day
$13.6M
20-day average traded
Fwd P/E
37.2×
forward earnings
ROIC−WACC
-1.2 pp
WACC 5.0%
Hurdle
n/a
no reverse DCF
Next earnings
172 days
27 Apr 2027
Close · CNYCN¥4.28
1D+0.2%
1W+5.2%
1M+0.7%
3M-6.8%
6M-26.5%
YTD-38.4%
1Y-42.2%
ATR %2.8%
52w lowhigh48.2% off high

What Star Lake Bioscience does

Guangdong biochemical company producing MSG, nucleotides and other fermentation-based food additives and fine chemicals.

In one line: A smaller Chinese fermentation/food-additive producer.

Products and services

  • MSG
  • Nucleotides (flavor enhancers)
  • Amino acids/fine chemicals

Customers

  • Food manufacturers
  • Foodservice/flavor industry

Where it sits in the supply chain

  • Specialty chemicals
  • Food additives
  • MSG, nucleotides, amino acids

What could go right

  • Food-additive demand growth

What could go wrong

  • Commodity pricing pressure
  • Fermentation feedstock cost swings

Moat: none. Commodity fermentation-chemical producer without differentiated pricing power.

Headquarters: Zhaoqing, Guangdong, China · Employees: 10,528

Named competitors

Star Lake Bioscience at a glance

Size Star Lake Bioscience (600866.SS) is a China Consumer Staples company (Food: Specialty/Candy) with a market value of $1.07B, the 2179th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥4.28 on 6 Nov 2026.

Performance Over six months the shares fell 26.5%, against -8.3% for the median peer and -16.4% for the China market (cap-weighted) — 5th lowest of 20 in its peer set.

Growth Revenue fell 3.0% over the last twelve months (peer median +7.8%); the operating margin is 0.4% (peer median 8.7%).

Valuation It trades at 37.2× forward earnings against a peer median of 17.7× (5th most expensive of 15).

Capital Return on invested capital runs 1.2 points below its cost of capital (5.0% WACC).

Next results Next results expected around 27 Apr 2027 (exchange calendar; dates can move).

Relative performance

8010011 May 202611 Aug 20266 Nov 2026Peer median 91600866.SS 74
Six months, rebased to 100: Star Lake Bioscience against the median of its 20 peers (local-currency closes).

Star Lake Bioscience financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥16.1BCN¥15.9BCN¥17.3BCN¥17.4BCN¥17.5B
Revenue growth—-8%0%0%—
Gross profitCN¥2.04BCN¥2.44BCN¥2.79BCN¥2.26BCN¥2.87B
EBITDAn/aCN¥2.02BCN¥2.42BCN¥2.02BCN¥2.71B
Net incomeCN¥19.7MCN¥979MCN¥943MCN¥678MCN¥608M
Free cash flow-CN¥2.33B-CN¥730MCN¥1.76BCN¥1.66BCN¥1.21B
Capital expenditureCN¥1.96BCN¥2.04BCN¥638MCN¥376MCN¥452M
Total debtCN¥7.98BCN¥6.36BCN¥4.15BCN¥4.40BCN¥5.04B

Quarterly statements and history in the cockpit →

Star Lake Bioscience competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-25%0%+25%+50%-20%0%+20%6001270018002815SENEA605339002650004990F03600929002956300138ITM26026050162201WESTMANORAMA600866.SS6-month return →1-month return →
Up and to the right = strong over both horizons. Star Lake Bioscience is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%20×40×60×2815SENEA004990F03600929002956300138605016BIKAJI2201007310MANORAMA600866.SSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Star Lake Bioscience is the large dot.

Star Lake Bioscience competitors and peer comparison

Head to head with its named competitors (600866.SS vs 600873.SS vs 0546.HK vs 600186.SS)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Star Lake Bioscience 600866.SS$1.07B-26%-3%0%37.2×n/a
MeiHua 600873.SS$2.99B-27%-3%4%14.5×n/a
Fufeng 0546.HK$1.31B-37%+1%4%7.4×n/a
Lotus 600186.SS$2.37B-18%+21%13%35.2×n/a

How Star Lake Bioscience compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Star Lake Bioscience against its 20 peers (data as of 6 Nov 2026)
Measure600866.SSPeer medianRank in peer set
1-month return+0.7%+0.7%11th highest of 21
6-month return-26.5%-8.3%5th lowest of 20
Distance from 52-week high-48.2%-24.9%lowest of 21
Revenue growth (TTM)-3.0%+7.8%5th lowest of 21
Operating margin0.4%8.7%5th lowest of 21
Forward P/E37.2×17.7×5th most expensive of 15
ROIC minus cost of capital-1.2 pp+1.0 pp8th lowest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Star Lake Bioscience 600866.SSChina$1.07B-26%-3%0%37.2×n/an/a
JinJian Cereals Industry 600127.SSChina$1.08B+64%+1%-1%n/an/an/a
ORION 001800.KSSouth Korea$1.06B-4%+15%15%n/a-16.5%+8.3%
ARIAKE JAPAN 2815.TJapan$1.04B-5%+3%17%17.4×-7.4%+6.1%
Jiangxi Qiyunshan Food 2797.HKHong Kong$1.10Bn/a-7%17%n/an/an/a
Seneca Foods SENEAUnited States$1.03B+9%+12%9%10.9×-15.1%+2.5%
Namchow Food Group (Shanghai) 605339.SSChina$1.01B-2%-5%-1%n/an/an/a
Jiajia Food 002650.SZChina$983M-25%-3%-11%n/a1.2%-10.0%
Lotte 004990.KSSouth Korea$1.18B-27%+1%2%69.5×n/an/a
Food Empire F03.SISingapore$952M-22%+14%16%12.7×-9.9%+14.9%
Snowsky Salt Industry 600929.SSChina$1.20B-29%+32%1%54.7×n/an/a
Guilin Seamild Foods 002956.SZChina$947M-14%+21%11%23.3×9.0%+17.0%
Chenguang Biotech 300138.SZChina$946M+13%-4%6%16.1×-1.0%+10.9%
Italmobiliare ITM.MIItaly$1.20B-8%+8%14%12.0×n/an/a
Nisshin OilliO 2602.TJapan$1.22B+13%+8%3%18.0×3.1%+10.5%
Shandong Bailong Chuangyuan Bio-Tech 605016.SSChina$1.24B-28%+19%32%18.4×8.8%+22.5%
Bikaji Foods International BIKAJI.NSIndia$1.27B-29%+14%10%37.4×38.6%+17.5%
Morinaga & 2201.TJapan$1.28B-8%+3%9%12.3×-5.7%+7.1%
Otoki 007310.KSSouth Korea$879M-13%+4%5%9.4×-6.5%+7.2%
Westrock Coffee WESTUnited States$878M+9%+39%0%n/an/an/a
Manorama Industries MANORAMA.NSIndia$1.31B+22%+60%24%39.3×33.4%+46.9%

Questions

Who are Star Lake Bioscience's main competitors?
Named competitors: MeiHua Holdings (600873.SS), Fufeng Group (0546.HK), Lotus Holdings (600186.SS). The cockpit's measured peer set (industry) also includes JinJian Cereals Industry (600127.SS), ORION (001800.KS), ARIAKE JAPAN (2815.T), Jiangxi Qiyunshan Food (2797.HK), Seneca Foods (SENEA), Namchow Food Group (Shanghai) (605339.SS).
Is Star Lake Bioscience expensive compared with its peers?
On forward p/e it trades at 37.2× against a peer median of 17.7×, 5th most expensive of 15 in its peer set.
How has Star Lake Bioscience stock performed?
Over six months to 6 Nov 2026 the shares returned -26.5% against -8.3% for the median peer; over one year -42.2%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.